A 10-Gene Classifier for Indeterminate Thyroid Nodules: Development and Multicenter Accuracy Study

Background: In most of the world, diagnostic surgery remains the most frequent approach for indeterminate thyroid cytology. Although several molecular tests are available for testing in centralized commercial laboratories in the United States, there are no available kits for local laboratory testing. The aim of this study was to develop a prototype in vitro diagnostic (IVD) gene classifier for the further characterization of nodules with an indeterminate thyroid cytology. Methods: In a first stage, the expression of 18 genes was determined by quantitative polymerase chain reaction (qPCR) in a broad histopathological spectrum of 114 fresh-tissue biopsies. Expression data were used to train several classifiers by supervised machine learning approaches. Classifiers were tested in an independent set of 139 samples. In a second stage, the best classifier was chosen as a model to develop a multiplexed-qPCR IVD prototype assay, which was tested in a prospective multicenter cohort of fine-needle aspiration biopsies. Results: In tissue biopsies, the best classifier, using only 10 genes, reached an optimal and consistent performance in the ninefold cross-validated testing set (sensitivity 93% and specificity 81%). In the multicenter cohort of fine-needle aspiration biopsy samples, the 10-gene signature, built into a multiplexed-qPCR IVD prototype, showed an area under the curve of 0.97, a positive predictive value of 78%, and a negative predictive value of 98%. By Bayes' theorem, the IVD prototype is expected to achieve a positive predictive value of 64–82% and a negative predictive value of 97–99% in patients with a cancer prevalence range of 20–40%. Conclusions: A new multiplexed-qPCR IVD prototype is reported that accurately classifies thyroid nodules and may provide a future solution suitable for local reference laboratory testing.

[1]  Stanley Lemeshow,et al.  Adequacy of Sample Size in Health Studies , 1990 .

[2]  G. McLachlan Discriminant Analysis and Statistical Pattern Recognition , 1992 .

[3]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[4]  Andrej Sali,et al.  Fold assessment for comparative protein structure modeling , 2007, Protein science : a publication of the Protein Society.

[5]  V. Beneš,et al.  The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. , 2009, Clinical chemistry.

[6]  Eric T. Wang,et al.  Molecular classification of thyroid nodules using high-dimensionality genomic data. , 2010, The Journal of clinical endocrinology and metabolism.

[7]  E. Mazzaferri,et al.  Thyroid cancer epidemiology and prognostic variables. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[8]  S. Steinberg,et al.  A prospective study evaluating the accuracy of using combined clinical factors and candidate diagnostic markers to refine the accuracy of thyroid fine needle aspiration biopsy. , 2010, Surgery.

[9]  W. Faquin,et al.  Update in Thyroid Fine Needle Aspiration , 2011, Endocrine pathology.

[10]  H. Höfler,et al.  Decentral gene expression analysis for ER+/Her2− breast cancer: results of a proficiency testing program for the EndoPredict assay , 2012, Virchows Archiv.

[11]  Darya Chudova,et al.  Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. , 2012, The New England journal of medicine.

[12]  Katia Zavaglia,et al.  A molecular computational model improves the preoperative diagnosis of thyroid nodules , 2012, BMC Cancer.

[13]  C. Denkert,et al.  Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test , 2012, BMC Cancer.

[14]  S. Wiseman,et al.  Cost-effectiveness of using a molecular diagnostic test to improve preoperative diagnosis of thyroid cancer. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[15]  Somak Roy,et al.  Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer. , 2013, The Journal of clinical endocrinology and metabolism.

[16]  K. Robinson,et al.  Increases in thyroid nodule fine-needle aspirations, operations, and diagnoses of thyroid cancer in the United States. , 2013, Surgery.

[17]  F. Frasca,et al.  Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors , 2013, Journal of cancer epidemiology.

[18]  R. Seethala,et al.  Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay , 2014, Cancer.

[19]  Louise Davies,et al.  Current thyroid cancer trends in the United States. , 2014, JAMA otolaryngology-- head & neck surgery.

[20]  Chao Zhang,et al.  The value of tumor markers in the diagnosis of papillary thyroid carcinoma alone and in combination. , 2014, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[21]  E. Labourier,et al.  Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology. , 2015, The Journal of clinical endocrinology and metabolism.

[22]  Mitchell E. Tublin,et al.  Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology , 2015, Thyroid : official journal of the American Thyroid Association.

[23]  Michael P. Gailey,et al.  Correlating thyroid cytology and histopathology: Implications for molecular testing , 2016, Head & neck.

[24]  S. Mandel,et al.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[25]  Brian C. Haynes,et al.  Molecular classification of thyroid lesions by combined testing for miRNA gene expression and somatic gene alterations , 2016, The journal of pathology. Clinical research.

[26]  V. Treviño,et al.  A robust biomarker of differential correlations improves the diagnosis of cytologically indeterminate thyroid cancers. , 2016, International journal of molecular medicine.

[27]  A. Tischler,et al.  Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors. , 2016, JAMA oncology.

[28]  E. Labourier Utility and cost‐effectiveness of molecular testing in thyroid nodules with indeterminate cytology , 2016, Clinical endocrinology.

[29]  Michiya Nishino Molecular cytopathology for thyroid nodules: A review of methodology and test performance , 2016, Cancer cytopathology.

[30]  J. Russell,et al.  Institutional prevalence of malignancy of indeterminate thyroid cytology is necessary but insufficient to accurately interpret molecular marker tests. , 2016, European journal of endocrinology.

[31]  Hemanathan Guhanandam,et al.  Expression of Cytokeratin-19 and Thyroperoxidase in Relation to Morphological Features in Non-Neoplastic and Neoplastic Lesions of Thyroid. , 2016, Journal of clinical and diagnostic research : JCDR.

[32]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .